Sustainability | October 14, 2022
JB Pharma publishes its maiden sustainability report
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
The MoU will enable both countries to promote research collaboration and building capacities in the field of the Indian Ayurvedic system of traditional medicines
The certification will open new avenues for our flagship brand “Dr Trust”, enabling them to export these devices to many more countries
The inspection of the facility was conducted from August 16-19, 2022.
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
India's healthcare system has shown great efficiency not only in providing diagnostic and management facilities but also in minimizing mortality and maximizing recovery
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
Subscribe To Our Newsletter & Stay Updated
